Cargando…
TACC3 in personalized medicine
Autores principales: | Murata, Stephen, Campo, Loredana, Breuer, Eun-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671950/ https://www.ncbi.nlm.nih.gov/pubmed/26682275 |
Ejemplares similares
-
Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
por: Murata, Stephen, et al.
Publicado: (2016) -
TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013) -
Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013) -
Aberrations of TACC1 and TACC3 are associated with ovarian cancer
por: Lauffart, Brenda, et al.
Publicado: (2005) -
FGFR3–TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle
por: Sarkar, Sourav, et al.
Publicado: (2017)